California Enters Insulin Manufacturing: Can We Expect to See a California Effect?
Bill of Health
JUNE 26, 2023
Initiatives like CalRx , which provide state intervention in drug manufacturing and distribution, can have far-reaching consequences for public health and access to medicines. On August 7, 2022, the US Senate passed the Inflation Reduction Act , which gives Medicare the power to negotiate prices of certain high-cost drugs.
Let's personalize your content